Ashish Baviskar

Affiliations: 
National Institute of Pharmaceutical Education and Research, Mohali 
Google:
"Ashish Baviskar"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Sankar K. Guchhait grad student 2009-2013 National Institute of Pharmaceutical Education and Research, Mohali
 (Synthesis, Biological Evaluation and Pre-formulation Studies of N-Fused Imidazole Derivatives as Topoisomerase II Inhibitors.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Darpan D, Joshi G, Amrutkar SM, et al. (2016) Synthesis and biological evaluation of new 2,5-dimethylthiophene/furan based N-acetyl pyrazolines as selective topoisomerase II inhibitors Rsc Advances. 6: 14880-14892
Negi A, Alex JM, Amrutkar SM, et al. (2015) Imine/amide-imidazole conjugates derived from 5-amino-4-cyano-N1-substituted benzyl imidazole: Microwave-assisted synthesis and anticancer activity via selective topoisomerase-II-α inhibition. Bioorganic & Medicinal Chemistry
Baviskar AT, Amrutkar SM, Trivedi N, et al. (2015) Switch in Site of Inhibition: A Strategy for Structure-Based Discovery of Human Topoisomerase IIα Catalytic Inhibitors. Acs Medicinal Chemistry Letters. 6: 481-5
Baviskar AT, Banerjee UC, Gupta M, et al. (2013) Synthesis of imine-pyrazolopyrimidinones and their mechanistic interventions on anticancer activity. Bioorganic & Medicinal Chemistry. 21: 5782-93
Kashyap M, Kandekar S, Baviskar AT, et al. (2013) Indenoindolone derivatives as topoisomerase II-inhibiting anticancer agents. Bioorganic & Medicinal Chemistry Letters. 23: 934-8
Singh S, Baviskar AT, Jain V, et al. (2013) 3-Formylchromone based topoisomerase IIα inhibitors: discovery of potent leads Medchemcomm. 4: 1257
Baviskar AT, Madaan C, Preet R, et al. (2011) N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIα and induce apoptosis in G1/S phase. Journal of Medicinal Chemistry. 54: 5013-30
See more...